{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:50:11Z","timestamp":1793746211465,"version":"4.6.1"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["16H05355"],"award-info":[{"award-number":["16H05355"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["19H03620"],"award-info":[{"award-number":["19H03620"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Promotion of Joint International Research from the Japan Society for the Promotion of Science","award":["18KK0228"],"award-info":[{"award-number":["18KK0228"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012629","name":"Japan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012629","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EURO CMC grant","award":["ANR-14-RARE-0005-02"],"award-info":[{"award-number":["ANR-14-RARE-0005-02"]}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"crossref","award":["ANR-FNS LTh-MSMD-CMCD"],"award-info":[{"award-number":["ANR-FNS LTh-MSMD-CMCD"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"crossref","award":["ANR-18-CE93-0008-01"],"award-info":[{"award-number":["ANR-18-CE93-0008-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127564"],"award-info":[{"award-number":["R01AI127564"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10875-020-00847-x","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T06:03:57Z","timestamp":1598508237000},"page":"1065-1081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":170,"title":["Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-5657","authenticated-orcid":false,"given":"Satoshi","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Boisson-Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"issue":"4","key":"847_CR1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1073\/pnas.86.4.1203","volume":"86","author":"TC Dale","year":"1989","unstructured":"Dale TC, Imam AM, Kerr IM, Stark GR. Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proc Natl Acad Sci U S A. 1989;86(4):1203\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"847_CR2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1101\/gad.3.9.1362","volume":"3","author":"DE Levy","year":"1989","unstructured":"Levy DE, Kessler DS, Pine R, Darnell JE Jr. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 1989;3(9):1362\u201371.","journal-title":"Genes Dev"},{"issue":"5164","key":"847_CR3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264(5164):1415\u201321.","journal-title":"Science"},{"key":"847_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","volume":"16","author":"WJ Leonard","year":"1998","unstructured":"Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16:293\u2013322.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"847_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/cyto.2001.0905","volume":"15","author":"PS Subramaniam","year":"2001","unstructured":"Subramaniam PS, Torres BA, Johnson HM. So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine. 2001;15(4):175\u201387.","journal-title":"Cytokine"},{"issue":"4","key":"847_CR6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2012.03.016","volume":"36","author":"JL Casanova","year":"2012","unstructured":"Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. 2012;36(4):515\u201328.","journal-title":"Immunity"},{"issue":"1","key":"847_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4(1):69\u201377.","journal-title":"Nat Immunol"},{"issue":"1","key":"847_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","volume":"4","author":"P Sheppard","year":"2003","unstructured":"Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003;4(1):63\u20138.","journal-title":"Nat Immunol"},{"key":"847_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem. 1998;67:227\u201364.","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"847_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3(9):651\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"28","key":"847_CR11","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","volume":"282","author":"C Schindler","year":"2007","unstructured":"Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007;282(28):20059\u201363.","journal-title":"J Biol Chem"},{"issue":"4","key":"847_CR12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","volume":"24","author":"S Boisson-Dupuis","year":"2012","unstructured":"Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol. 2012;24(4):364\u201378.","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"847_CR13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.coviro.2011.10.016","volume":"1","author":"V Sancho-Shimizu","year":"2011","unstructured":"Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL. Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol. 2011;1(6):487\u201396.","journal-title":"Curr Opin Virol"},{"issue":"3","key":"847_CR14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","volume":"33","author":"S Dupuis","year":"2003","unstructured":"Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, et al. Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33(3):388\u201391.","journal-title":"Nat Genet"},{"issue":"8","key":"847_CR15","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.4049\/jimmunol.176.8.5078","volume":"176","author":"A Chapgier","year":"2006","unstructured":"Chapgier A, Wynn RF, Jouanguy E, Filipe-Santos O, Zhang S, Feinberg J, et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol. 2006;176(8):5078\u201383.","journal-title":"J Immunol"},{"issue":"7","key":"847_CR16","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2011-01-330571","volume":"118","author":"D Vairo","year":"2011","unstructured":"Vairo D, Tassone L, Tabellini G, Tamassia N, Gasperini S, Bazzoni F, et al. Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation. Blood. 2011;118(7):1806\u201317.","journal-title":"Blood"},{"issue":"6","key":"847_CR17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1172\/JCI37083","volume":"119","author":"A Chapgier","year":"2009","unstructured":"Chapgier A, Kong XF, Boisson-Dupuis S, Jouanguy E, Averbuch D, Feinberg J, et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest. 2009;119(6):1502\u201314.","journal-title":"J Clin Invest"},{"issue":"26","key":"847_CR18","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1182\/blood-2010-04-280586","volume":"116","author":"XF Kong","year":"2010","unstructured":"Kong XF, Ciancanelli M, Al-Hajjar S, Alsina L, Zumwalt T, Bustamante J, et al. A novel form of human STAT1 deficiency impairing early but not late responses to interferons. Blood. 2010;116(26):5895\u2013906.","journal-title":"Blood"},{"issue":"2","key":"847_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-010-9480-8","volume":"31","author":"IA Kristensen","year":"2011","unstructured":"Kristensen IA, Veirum JE, Moller BK, Christiansen M. Novel STAT1 alleles in a patient with impaired resistance to mycobacteria. J Clin Immunol. 2011;31(2):265\u201371.","journal-title":"J Clin Immunol"},{"issue":"5528","key":"847_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","volume":"293","author":"S Dupuis","year":"2001","unstructured":"Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science. 2001;293(5528):300\u20133.","journal-title":"Science"},{"issue":"8","key":"847_CR21","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","volume":"2","author":"A Chapgier","year":"2006","unstructured":"Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet. 2006;2(8):e131.","journal-title":"PLoS Genet"},{"issue":"9","key":"847_CR22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/humu.22113","volume":"33","author":"M Tsumura","year":"2012","unstructured":"Tsumura M, Okada S, Sakai H, Yasunaga S, Ohtsubo M, Murata T, et al. Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease. Hum Mutat. 2012;33(9):1377\u201387.","journal-title":"Hum Mutat"},{"issue":"1","key":"847_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.09.035","volume":"140","author":"R Kagawa","year":"2017","unstructured":"Kagawa R, Fujiki R, Tsumura M, Sakata S, Nishimura S, Itan Y, et al. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. J Allergy Clin Immunol. 2017;140(1):232\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"847_CR24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3324\/haematol.2013.083741","volume":"98","author":"O Hirata","year":"2013","unstructured":"Hirata O, Okada S, Tsumura M, Kagawa R, Miki M, Kawaguchi H, et al. Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis. Haematologica. 2013;98(10):1641\u20139.","journal-title":"Haematologica"},{"issue":"4","key":"847_CR25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10875-012-9659-2","volume":"32","author":"EP Sampaio","year":"2012","unstructured":"Sampaio EP, Bax HI, Hsu AP, Kristosturyan E, Pechacek J, Chandrasekaran P, et al. A novel STAT1 mutation associated with disseminated mycobacterial disease. J Clin Immunol. 2012;32(4):681\u20139.","journal-title":"J Clin Immunol"},{"key":"847_CR26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clim.2016.11.004","volume":"174","author":"M Ueki","year":"2017","unstructured":"Ueki M, Yamada M, Ito K, Tozawa Y, Morino S, Horikoshi Y, et al. A heterozygous dominant-negative mutation in the coiled-coil domain of STAT1 is the cause of autosomal-dominant Mendelian susceptibility to mycobacterial diseases. Clin Immunol. 2017;174:24\u201331.","journal-title":"Clin Immunol"},{"issue":"6","key":"847_CR27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454\u201370.","journal-title":"Semin Immunol"},{"issue":"4","key":"847_CR28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/imcb.12210","volume":"97","author":"J Rosain","year":"2019","unstructured":"Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol. 2019;97(4):360\u20137.","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"847_CR29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","volume":"12","author":"A Puel","year":"2012","unstructured":"Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12(6):616\u201322.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"847_CR30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MOP.0000000000000031","volume":"25","author":"F Lanternier","year":"2013","unstructured":"Lanternier F, Cypowyj S, Picard C, Bustamante J, Lortholary O, Casanova JL, et al. Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr. 2013;25(6):736\u201347.","journal-title":"Curr Opin Pediatr"},{"issue":"12","key":"847_CR31","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/cti.2016.71","volume":"5","author":"S Okada","year":"2016","unstructured":"Okada S, Puel A, Casanova JL, Kobayashi M. Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Clin Transl Immunol. 2016;5(12):e114.","journal-title":"Clin Transl Immunol"},{"key":"847_CR32","doi-asserted-by":"crossref","unstructured":"Puel A. Human inborn errors of immunity underlying superficial or invasive candidiasis. Hum Genet. 2020.","DOI":"10.1007\/s00439-020-02141-7"},{"issue":"7157","key":"847_CR33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058\u201362.","journal-title":"Nature"},{"issue":"16","key":"847_CR34","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608\u201319.","journal-title":"N Engl J Med"},{"issue":"9","key":"847_CR35","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","volume":"216","author":"S Spencer","year":"2019","unstructured":"Spencer S, Kostel Bal S, Egner W, Lango Allen H, Raza SI, Ma CA, et al. Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses. J Exp Med. 2019;216(9):1986\u201398.","journal-title":"J Exp Med"},{"key":"847_CR36","unstructured":"Beziat V, Tavernier SJ, Chen YH, Ma CS, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217(6)."},{"issue":"6248","key":"847_CR37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.aaa4282","volume":"349","author":"S Okada","year":"2015","unstructured":"Okada S, Markle JG, Deenick EK, Mele F, Averbuch D, Lagos M, et al. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 2015;349(6248):606\u201313.","journal-title":"Science"},{"key":"847_CR38","unstructured":"Beziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018;3(24)."},{"key":"847_CR39","doi-asserted-by":"crossref","unstructured":"Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC, et al. ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol. 2018;3(24).","DOI":"10.1126\/sciimmunol.aat4941"},{"issue":"2","key":"847_CR40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","volume":"207","author":"K Kisand","year":"2010","unstructured":"Kisand K, Boe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207(2):299\u2013308.","journal-title":"J Exp Med"},{"issue":"2","key":"847_CR41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","volume":"207","author":"A Puel","year":"2010","unstructured":"Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207(2):291\u20137.","journal-title":"J Exp Med"},{"issue":"6025","key":"847_CR42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","volume":"332","author":"A Puel","year":"2011","unstructured":"Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332(6025):65\u20138.","journal-title":"Science."},{"issue":"2","key":"847_CR43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","volume":"206","author":"HR Conti","year":"2009","unstructured":"Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206(2):299\u2013311.","journal-title":"J Exp Med"},{"issue":"9","key":"847_CR44","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.4049\/jimmunol.1001153","volume":"185","author":"S Kagami","year":"2010","unstructured":"Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol. 2010;185(9):5453\u201362.","journal-title":"J Immunol"},{"issue":"9","key":"847_CR45","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/eji.201242605","volume":"42","author":"S Cypowyj","year":"2012","unstructured":"Cypowyj S, Picard C, Marodi L, Casanova JL, Puel A. Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol. 2012;42(9):2246\u201354.","journal-title":"Eur J Immunol"},{"key":"847_CR46","doi-asserted-by":"crossref","unstructured":"Sparber F, LeibundGut-Landmann S. Interleukin-17 in antifungal immunity. Pathogens. 2019;8(2).","DOI":"10.3390\/pathogens8020054"},{"key":"847_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smim.2017.12.008","volume":"36","author":"JL Casanova","year":"2018","unstructured":"Casanova JL, Abel L. Human genetics of infectious diseases: unique insights into immunological redundancy. Semin Immunol. 2018;36:1\u201312.","journal-title":"Semin Immunol"},{"issue":"51","key":"847_CR48","doi-asserted-by":"crossref","first-page":"E8277","DOI":"10.1073\/pnas.1618300114","volume":"113","author":"R Levy","year":"2016","unstructured":"Levy R, Okada S, Beziat V, Moriya K, Liu C, Chai LY, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113(51):E8277\u2013E85.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"847_CR49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.20141065","volume":"212","author":"Y Ling","year":"2015","unstructured":"Ling Y, Cypowyj S, Aytekin C, Galicchio M, Camcioglu Y, Nepesov S, et al. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J Exp Med. 2015;212(5):619\u201331.","journal-title":"J Exp Med"},{"issue":"4","key":"847_CR50","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2015.07.053","volume":"137","author":"F Fellmann","year":"2016","unstructured":"Fellmann F, Angelini F, Wassenberg J, Perreau M, Arenas Ramirez N, Simon G, et al. IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation. J Allergy Clin Immunol. 2016;137(4):1189\u201396 e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"847_CR51","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","volume":"39","author":"B Boisson","year":"2013","unstructured":"Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, et al. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 2013;39(4):676\u201386.","journal-title":"Immunity."},{"issue":"6","key":"847_CR52","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-019-00664-x","volume":"39","author":"S Bhattad","year":"2019","unstructured":"Bhattad S, Dinakar C, Pinnamaraju H, Ganapathy A, Mannan A. Chronic mucocutaneous candidiasis in an adolescent boy due to a novel mutation in TRAF3IP2. J Clin Immunol. 2019;39(6):596\u20139.","journal-title":"J Clin Immunol"},{"key":"847_CR53","doi-asserted-by":"crossref","unstructured":"Nemer G, El-Hachem N, Eid E, Hamie L, Bardawil T, Khalil S, et al. A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans. Clin Genet. 2020.","DOI":"10.1111\/cge.13767"},{"key":"847_CR54","doi-asserted-by":"crossref","unstructured":"Li J, Ritelli M, Ma CS, Rao G, Habib T, Corvilain E, et al. Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-beta. Sci Immunol. 2019;4(41).","DOI":"10.1126\/sciimmunol.aax7965"},{"issue":"8","key":"847_CR55","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635\u201348.","journal-title":"J Exp Med"},{"issue":"1","key":"847_CR56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54\u201361.","journal-title":"N Engl J Med"},{"issue":"1","key":"847_CR57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","volume":"36","author":"M Depner","year":"2016","unstructured":"Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic Mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol. 2016;36(1):73\u201384.","journal-title":"J Clin Immunol"},{"issue":"25","key":"847_CR58","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154\u201364.","journal-title":"Blood"},{"issue":"4","key":"847_CR59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1189\/jlb.0513250","volume":"95","author":"Y Mizoguchi","year":"2014","unstructured":"Mizoguchi Y, Tsumura M, Okada S, Hirata O, Minegishi S, Imai K, et al. Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis. J Leukoc Biol. 2014;95(4):667\u201376.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"847_CR60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jmedgenet-2013-101570","volume":"50","author":"B Soltesz","year":"2013","unstructured":"Soltesz B, Toth B, Shabashova N, Bondarenko A, Okada S, Cypowyj S, et al. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe. J Med Genet. 2013;50(9):567\u201378.","journal-title":"J Med Genet"},{"issue":"1","key":"847_CR61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s10875-019-00688-3","volume":"40","author":"X Chen","year":"2020","unstructured":"Chen X, Xu Q, Li X, Wang L, Yang L, Chen Z, et al. Molecular and phenotypic characterization of nine patients with STAT1 GOF mutations in China. J Clin Immunol. 2020;40(1):82\u201395.","journal-title":"J Clin Immunol"},{"key":"847_CR62","doi-asserted-by":"crossref","first-page":"101713","DOI":"10.1016\/j.scr.2020.101713","volume":"43","author":"K Haake","year":"2020","unstructured":"Haake K, Wustefeld T, Merkert S, Luttge D, Gohring G, Auber B, et al. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis. Stem Cell Res. 2020;43:101713.","journal-title":"Stem Cell Res"},{"issue":"2","key":"847_CR63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4168\/aair.2020.12.2.292","volume":"12","author":"WK Kwon","year":"2020","unstructured":"Kwon WK, Choi S, Kim HJ, Huh HJ, Kang JM, Kim YJ, et al. Flow cytometry for the diagnosis of primary immunodeficiency diseases: a single center experience. Allergy Asthma Immunol Res. 2020;12(2):292\u2013305.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"3","key":"847_CR64","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaci.2019.11.028","volume":"145","author":"JS Lee","year":"2020","unstructured":"Lee JS, An Y, Yoon CJ, Kim JY, Kim KH, Freeman AF, et al. Germline gain-of-function mutation of STAT1 rescued by somatic mosaicism in immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like disorder. J Allergy Clin Immunol. 2020;145(3):1017\u201321.","journal-title":"J Allergy Clin Immunol"},{"key":"847_CR65","doi-asserted-by":"crossref","unstructured":"Moriya K, Suzuki T, Uchida N, Nakano T, Katayama S, Irie M, et al. Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation. Int J Hematol. 2020.","DOI":"10.1007\/s12185-020-02860-7"},{"key":"847_CR66","doi-asserted-by":"crossref","unstructured":"Saez-de-Ocariz M, Suarez-Gutierrez M, Migaud M, O\u2019Farrill-Romanillos P, Casanova JL, Seguramendez NH, et al. Rosacea as a striking feature in family members with a STAT1 gain-of-function mutation. J Eur Acad Dermatol Venereol. 2020.","DOI":"10.1111\/jdv.16241"},{"issue":"3","key":"847_CR67","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/odi.12881","volume":"25","author":"B Carey","year":"2019","unstructured":"Carey B, Lambourne J, Porter S, Hodgson T. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1. Oral Dis. 2019;25(3):684\u201392.","journal-title":"Oral Dis"},{"key":"847_CR68","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3389\/fimmu.2019.02325","volume":"10","author":"F Rudilla","year":"2019","unstructured":"Rudilla F, Franco-Jarava C, Martinez-Gallo M, Garcia-Prat M, Martin-Nalda A, Riviere J, et al. Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings. Front Immunol. 2019;10:2325.","journal-title":"Front Immunol"},{"issue":"6","key":"847_CR69","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jaci.2013.01.004","volume":"131","author":"N Romberg","year":"2013","unstructured":"Romberg N, Morbach H, Lawrence MG, Kim S, Kang I, Holland SM, et al. Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. J Allergy Clin Immunol. 2013;131(6):1691\u20133.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"847_CR70","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1084\/jem.20161427","volume":"214","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Ma CA, Lawrence MG, Break TJ, O'Connell MP, Lyons JJ, et al. PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients. J Exp Med. 2017;214(9):2523\u201333.","journal-title":"J Exp Med"},{"issue":"4","key":"847_CR71","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/jid.2013.480","volume":"134","author":"N Mekki","year":"2014","unstructured":"Mekki N, Ben-Mustapha I, Liu L, Boussofara L, Okada S, Cypowyj S, et al. IL-17 T cells' defective differentiation in vitro despite normal range ex vivo in chronic mucocutaneous candidiasis due to STAT1 mutation. J Invest Dermatol. 2014;134(4):1155\u20137.","journal-title":"J Invest Dermatol."},{"issue":"2","key":"847_CR72","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","volume":"141","author":"JW Leiding","year":"2018","unstructured":"Leiding JW, Okada S, Hagin D, Abinun M, Shcherbina A, Balashov DN, et al. Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations. J Allergy Clin Immunol. 2018;141(2):704\u201317 e5.","journal-title":"J Allergy Clin Immunol"},{"key":"847_CR73","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3389\/fimmu.2019.01433","volume":"10","author":"O Zimmerman","year":"2019","unstructured":"Zimmerman O, Olbrich P, Freeman AF, Rosen LB, Uzel G, Zerbe CS, et al. STAT1 gain-of-function mutations cause high Total STAT1 levels with normal dephosphorylation. Front Immunol. 2019;10:1433.","journal-title":"Front Immunol"},{"key":"847_CR74","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3389\/fimmu.2019.00768","volume":"10","author":"MC van Zelm","year":"2019","unstructured":"van Zelm MC, Bosco JJ, Aui PM, De Jong S, Hore-Lacy F, O'Hehir RE, et al. Impaired STAT3-dependent upregulation of IL2Ralpha in B cells of a patient with a STAT1 gain-of-function mutation. Front Immunol. 2019;10:768.","journal-title":"Front Immunol"},{"issue":"1","key":"847_CR75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.annder.2019.09.597","volume":"147","author":"B Baghad","year":"2020","unstructured":"Baghad B, Benhsaien I, El Fatoiki FZ, Migaud M, Puel A, Chiheb S, et al. Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections. Ann Dermatol Venereol. 2020;147(1):41\u20135.","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"847_CR76","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gene.2016.04.006","volume":"586","author":"R Kobbe","year":"2016","unstructured":"Kobbe R, Kolster M, Fuchs S, Schulze-Sturm U, Jenderny J, Kochhan L, et al. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation. Gene. 2016;586(2):234\u20138.","journal-title":"Gene."},{"issue":"6","key":"847_CR77","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2013.01.052","volume":"131","author":"EP Sampaio","year":"2013","unstructured":"Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, et al. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol. 2013;131(6):1624\u201334.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"847_CR78","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jaci.2017.08.040","volume":"141","author":"A Vargas-Hernandez","year":"2018","unstructured":"Vargas-Hernandez A, Mace EM, Zimmerman O, Zerbe CS, Freeman AF, Rosenzweig S, et al. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2018;141(6):2142\u201355 e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"847_CR79","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/ijd.13427","volume":"56","author":"X Wang","year":"2017","unstructured":"Wang X, Zhang R, Wu W, Wang A, Wan Z, van de Veerdonk FL, et al. New and recurrent STAT1 mutations in seven Chinese patients with chronic mucocutaneous candidiasis. Int J Dermatol. 2017;56(2):e30\u2013e3.","journal-title":"Int J Dermatol"},{"issue":"4","key":"847_CR80","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jaci.2012.11.005","volume":"131","author":"X Wang","year":"2013","unstructured":"Wang X, Lin Z, Gao L, Wang A, Wan Z, Chen W, et al. Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis. J Allergy Clin Immunol. 2013;131(4):1242\u20133.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"847_CR81","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10875-018-0519-6","volume":"38","author":"M Bloomfield","year":"2018","unstructured":"Bloomfield M, Kanderova V, Parackova Z, Vrabcova P, Svaton M, Fronkova E, et al. Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation. J Clin Immunol. 2018;38(5):589\u2013601.","journal-title":"J Clin Immunol"},{"issue":"6","key":"847_CR82","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","volume":"131","author":"G Uzel","year":"2013","unstructured":"Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013;131(6):1611\u201323.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"847_CR83","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cei.12746","volume":"184","author":"F Dhalla","year":"2016","unstructured":"Dhalla F, Fox H, Davenport EE, Sadler R, Anzilotti C, van Schouwenburg PA, et al. Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility. Clin Exp Immunol. 2016;184(2):216\u201327.","journal-title":"Clin Exp Immunol"},{"key":"847_CR84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2017.03.018","volume":"126","author":"O Breuer","year":"2017","unstructured":"Breuer O, Daum H, Cohen-Cymberknoh M, Unger S, Shoseyov D, Stepensky P, et al. Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis. Respir Med. 2017;126:39\u201345.","journal-title":"Respir Med"},{"key":"847_CR85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clim.2017.01.012","volume":"178","author":"M Dadak","year":"2017","unstructured":"Dadak M, Jacobs R, Skuljec J, Jirmo AC, Yildiz O, Donnerstag F, et al. Gain-of-function STAT1 mutations are associated with intracranial aneurysms. Clin Immunol. 2017;178:79\u201385.","journal-title":"Clin Immunol"},{"key":"847_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2015.12.010","volume":"164","author":"L Dotta","year":"2016","unstructured":"Dotta L, Scomodon O, Padoan R, Timpano S, Plebani A, Soresina A, et al. Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease. Clin Immunol. 2016;164:1\u20139.","journal-title":"Clin Immunol"},{"issue":"8","key":"847_CR87","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3349\/ymj.2018.59.8.1004","volume":"59","author":"HJ Huh","year":"2018","unstructured":"Huh HJ, Jhun BW, Choi SR, Kim YJ, Yun SA, Nham E, et al. Bronchiectasis and recurrent respiratory infections with a de novo STAT1 gain-of-function variant: first case in Korea. Yonsei Med J. 2018;59(8):1004\u20137.","journal-title":"Yonsei Med J"},{"issue":"5","key":"847_CR88","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/2050640616684404","volume":"5","author":"S Koo","year":"2017","unstructured":"Koo S, Kejariwal D, Al-Shehri T, Dhar A, Lilic D. Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation. United European Gastroenterol J. 2017;5(5):625\u201331.","journal-title":"United European Gastroenterol J"},{"key":"847_CR89","doi-asserted-by":"crossref","unstructured":"Nielsen J, Kofod-Olsen E, Spaun E, Larsen CS, Christiansen M, Mogensen TH. A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis. BMJ Case Rep. 2015;2015.","DOI":"10.1136\/bcr-2015-211372"},{"issue":"2","key":"847_CR90","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaci.2016.10.051","volume":"140","author":"G Tabellini","year":"2017","unstructured":"Tabellini G, Vairo D, Scomodon O, Tamassia N, Ferraro RM, Patrizi O, et al. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2017;140(2):553\u201364 e4.","journal-title":"J Allergy Clin Immunol"},{"key":"847_CR91","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3389\/fimmu.2019.02189","volume":"10","author":"PP Lee","year":"2019","unstructured":"Lee PP, Lao-Araya M, Yang J, Chan KW, Ma H, Pei LC, et al. Application of flow cytometry in the diagnostics pipeline of primary immunodeficiencies underlying disseminated Talaromyces marneffei infection in HIV-negative children. Front Immunol. 2019;10:2189.","journal-title":"Front Immunol"},{"issue":"5","key":"847_CR92","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/eji.201847955","volume":"49","author":"E Kaleviste","year":"2019","unstructured":"Kaleviste E, Saare M, Leahy TR, Bondet V, Duffy D, Mogensen TH, et al. Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined. Eur J Immunol. 2019;49(5):790\u2013800.","journal-title":"Eur J Immunol"},{"key":"847_CR93","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41525-018-0063-6","volume":"3","author":"A Ovadia","year":"2018","unstructured":"Ovadia A, Sharfe N, Hawkins C, Laughlin S, Roifman CM. Two different STAT1 gain-of-function mutations lead to diverse IFN-gamma-mediated gene expression. NPJ Genom Med. 2018;3:23.","journal-title":"NPJ Genom Med"},{"issue":"6","key":"847_CR94","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10875-012-9744-6","volume":"32","author":"T Hori","year":"2012","unstructured":"Hori T, Ohnishi H, Teramoto T, Tsubouchi K, Naiki T, Hirose Y, et al. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism. J Clin Immunol. 2012;32(6):1213\u201320.","journal-title":"J Clin Immunol"},{"issue":"2","key":"847_CR95","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2015.06.028","volume":"137","author":"S Kataoka","year":"2016","unstructured":"Kataoka S, Muramatsu H, Okuno Y, Hayashi Y, Mizoguchi Y, Tsumura M, et al. Extrapulmonary tuberculosis mimicking Mendelian susceptibility to mycobacterial disease in a patient with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation. J Allergy Clin Immunol. 2016;137(2):619\u201322 e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"847_CR96","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2018.11.033","volume":"143","author":"H Niehues","year":"2019","unstructured":"Niehues H, Rosler B, van der Krieken DA, van Vlijmen-Willems I, Rodijk-Olthuis D, Peppelman M, et al. STAT1 gain-of-function compromises skin host defense in the context of IFN-gamma signaling. J Allergy Clin Immunol. 2019;143(4):1626\u20139 e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"847_CR97","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2013.04.018","volume":"132","author":"G Wildbaum","year":"2013","unstructured":"Wildbaum G, Shahar E, Katz R, Karin N, Etzioni A, Pollack S. Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: complete clinical remission with restoration of IL-17 secretion. J Allergy Clin Immunol. 2013;132(3):761\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"847_CR98","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/cid\/civ1220","volume":"62","author":"CS Zerbe","year":"2016","unstructured":"Zerbe CS, Marciano BE, Katial RK, Santos CB, Adamo N, Hsu AP, et al. Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature. Clin Infect Dis. 2016;62(8):986\u201394.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"847_CR99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/pde.14011","volume":"37","author":"V Molho-Pessach","year":"2020","unstructured":"Molho-Pessach V, Meltser A, Kamshov A, Ramot Y, Zlotogorski A. STAT1 gain-of-function and chronic demodicosis. Pediatr Dermatol. 2020;37(1):153\u20135.","journal-title":"Pediatr Dermatol"},{"key":"847_CR100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molimm.2019.07.008","volume":"114","author":"J Petersen","year":"2019","unstructured":"Petersen J, Staab J, Bader O, Buhl T, Ivetic A, Meyer T. Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants. Mol Immunol. 2019;114:30\u201340.","journal-title":"Mol Immunol"},{"issue":"1","key":"847_CR101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10875-014-0111-7","volume":"35","author":"SS Kilic","year":"2015","unstructured":"Kilic SS, Puel A, Casanova JL. Orf infection in a patient with Stat1 gain-of-function. J Clin Immunol. 2015;35(1):80\u20133.","journal-title":"J Clin Immunol"},{"issue":"12","key":"847_CR102","doi-asserted-by":"crossref","first-page":"e29248","DOI":"10.1371\/journal.pone.0029248","volume":"6","author":"SP Smeekens","year":"2011","unstructured":"Smeekens SP, Plantinga TS, van de Veerdonk FL, Heinhuis B, Hoischen A, Joosten LA, et al. STAT1 hyperphosphorylation and defective IL12R\/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS One. 2011;6(12):e29248.","journal-title":"PLoS One"},{"key":"847_CR103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2015.05.183","volume":"196","author":"M Tanimura","year":"2015","unstructured":"Tanimura M, Dohi K, Hirayama M, Sato Y, Sugiura E, Nakajima H, et al. Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation. Int J Cardiol. 2015;196:88\u201390.","journal-title":"Int J Cardiol"},{"issue":"9835","key":"847_CR104","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0140-6736(12)60365-1","volume":"379","author":"B Toth","year":"2012","unstructured":"Toth B, Mehes L, Tasko S, Szalai Z, Tulassay Z, Cypowyj S, et al. Herpes in STAT1 gain-of-function mutation [corrected]. Lancet. 2012;379(9835):2500.","journal-title":"Lancet."},{"issue":"4","key":"847_CR105","doi-asserted-by":"crossref","first-page":"ofx202","DOI":"10.1093\/ofid\/ofx202","volume":"4","author":"O Zimmerman","year":"2017","unstructured":"Zimmerman O, Rosler B, Zerbe CS, Rosen LB, Hsu AP, Uzel G, et al. Risks of ruxolitinib in STAT1 gain-of-function-associated severe fungal disease. Open Forum Infect Dis. 2017;4(4):ofx202.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"847_CR106","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.1401467","volume":"193","author":"Y Yamazaki","year":"2014","unstructured":"Yamazaki Y, Yamada M, Kawai T, Morio T, Onodera M, Ueki M, et al. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody. J Immunol. 2014;193(10):4880\u20137.","journal-title":"J Immunol"},{"issue":"4","key":"847_CR107","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10875-018-0513-z","volume":"38","author":"AE Smyth","year":"2018","unstructured":"Smyth AE, Kaleviste E, Snow A, Kisand K, McMahon CJ, Cant AJ, et al. Aortic calcification in a patient with a gain-of-function STAT1 mutation. J Clin Immunol. 2018;38(4):468\u201370.","journal-title":"J Clin Immunol"},{"issue":"1","key":"847_CR108","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12969-019-0349-y","volume":"17","author":"I Tirosh","year":"2019","unstructured":"Tirosh I, Spielman S, Barel O, Ram R, Stauber T, Paret G, et al. Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies. Pediatr Rheumatol Online J. 2019;17(1):52.","journal-title":"Pediatr Rheumatol Online J"},{"key":"847_CR109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fped.2017.00055","volume":"5","author":"JC Aldave Becerra","year":"2017","unstructured":"Aldave Becerra JC, Cachay RE. A 3-year-old girl with recurrent infections and autoimmunity due to a STAT1 gain-of-function mutation: the expanding clinical presentation of primary immunodeficiencies. Front Pediatr. 2017;5:55.","journal-title":"Front Pediatr"},{"issue":"3","key":"847_CR110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaci.2013.09.032","volume":"133","author":"N Sharfe","year":"2014","unstructured":"Sharfe N, Nahum A, Newell A, Dadi H, Ngan B, Pereira SL, et al. Fatal combined immunodeficiency associated with heterozygous mutation in STAT1. J Allergy Clin Immunol. 2014;133(3):807\u201317.","journal-title":"J Allergy Clin Immunol"},{"issue":"2 Pt C","key":"847_CR111","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.molimm.2015.09.014","volume":"68","author":"L Martinez-Martinez","year":"2015","unstructured":"Martinez-Martinez L, Martinez-Saavedra MT, Fuentes-Prior P, Barnadas M, Rubiales MV, Noda J, et al. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-gamma-mediated responses in chronic mucocutaneous candidiasis. Mol Immunol. 2015;68(2 Pt C):597\u2013605.","journal-title":"Mol Immunol"},{"issue":"7","key":"847_CR112","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10875-016-0312-3","volume":"36","author":"S Baris","year":"2016","unstructured":"Baris S, Alroqi F, Kiykim A, Karakoc-Aydiner E, Ogulur I, Ozen A, et al. Severe early-onset combined immunodeficiency due to heterozygous gain-of-function mutations in STAT1. J Clin Immunol. 2016;36(7):641\u20138.","journal-title":"J Clin Immunol"},{"issue":"1","key":"847_CR113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10875-018-0575-y","volume":"39","author":"A Kiykim","year":"2019","unstructured":"Kiykim A, Charbonnier LM, Akcay A, Karakoc-Aydiner E, Ozen A, Ozturk G, et al. Hematopoietic stem cell transplantation in patients with heterozygous STAT1 gain-of-function mutation. J Clin Immunol. 2019;39(1):37\u201344.","journal-title":"J Clin Immunol"},{"issue":"3","key":"847_CR114","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3899\/jrheum.180210","volume":"46","author":"K Maeshima","year":"2019","unstructured":"Maeshima K, Ishii K, Shibata H. An adult fatal case with a STAT1 gain-of-function mutation associated with multiple autoimmune diseases. J Rheumatol. 2019;46(3):325\u20137.","journal-title":"J Rheumatol"},{"issue":"12","key":"847_CR115","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1111\/jdv.14413","volume":"31","author":"J Second","year":"2017","unstructured":"Second J, Korganow AS, Jannier S, Puel A, Lipsker D. Rosacea and demodicidosis associated with gain-of-function mutation in STAT1. J Eur Acad Dermatol Venereol. 2017;31(12):e542\u2013e4.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"847_CR116","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaci.2013.08.051","volume":"133","author":"PP Lee","year":"2014","unstructured":"Lee PP, Mao H, Yang W, Chan KW, Ho MH, Lee TL, et al. Penicillium marneffei infection and impaired IFN-gamma immunity in humans with autosomal-dominant gain-of-phosphorylation STAT1 mutations. J Allergy Clin Immunol. 2014;133(3):894\u20136 e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"847_CR117","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2014.02.037","volume":"134","author":"N Kumar","year":"2014","unstructured":"Kumar N, Hanks ME, Chandrasekaran P, Davis BC, Hsu AP, Van Wagoner NJ, et al. Gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation-related primary immunodeficiency is associated with disseminated mucormycosis. J Allergy Clin Immunol. 2014;134(1):236\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"847_CR118","first-page":"2846928","volume":"2017","author":"S Eren Akarcan","year":"2017","unstructured":"Eren Akarcan S, Ulusoy Severcan E, Edeer Karaca N, Isik E, Aksu G, Migaud M, et al. Gain-of-function mutations in STAT1: a recently defined cause for chronic mucocutaneous candidiasis disease mimicking combined immunodeficiencies. Case Rep Immunol. 2017;2017:2846928.","journal-title":"Case Rep Immunol"},{"issue":"2","key":"847_CR119","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1556\/030.64.2017.014","volume":"64","author":"N Eslami","year":"2017","unstructured":"Eslami N, Tavakol M, Mesdaghi M, Gharegozlou M, Casanova JL, Puel A, et al. A gain-of-function mutation of STAT1: a novel genetic factor contributing to chronic mucocutaneous candidiasis. Acta Microbiol Immunol Hung. 2017;64(2):191\u2013201.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"5","key":"847_CR120","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2014.05.044","volume":"134","author":"G Frans","year":"2014","unstructured":"Frans G, Moens L, Schaballie H, Van Eyck L, Borgers H, Wuyts M, et al. Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding. J Allergy Clin Immunol. 2014;134(5):1209\u201313 e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"847_CR121","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaci.2016.02.009","volume":"138","author":"E Grunebaum","year":"2016","unstructured":"Grunebaum E, Kim VH, Somers GR, Shammas A, Roifman CM. Bone marrow transplantation for monoallelic signal transducer and activator of transcription 1 deficiency. J Allergy Clin Immunol. 2016;138(2):612\u20135 e1.","journal-title":"J Allergy Clin Immunol"},{"key":"847_CR122","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3389\/fimmu.2017.01651","volume":"8","author":"S Pedraza-Sanchez","year":"2017","unstructured":"Pedraza-Sanchez S, Lezana-Fernandez JL, Gonzalez Y, Martinez-Robles L, Ventura-Ayala ML, Sadowinski-Pine S, et al. Disseminated tuberculosis and chronic mucocutaneous candidiasis in a patient with a gain-of-function mutation in signal transduction and activator of transcription 1. Front Immunol. 2017;8:1651.","journal-title":"Front Immunol"},{"issue":"3","key":"847_CR123","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.1200926","volume":"189","author":"S Takezaki","year":"2012","unstructured":"Takezaki S, Yamada M, Kato M, Park MJ, Maruyama K, Yamazaki Y, et al. Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain. J Immunol. 2012;189(3):1521\u20136.","journal-title":"J Immunol"},{"issue":"2","key":"847_CR124","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/pai.12496","volume":"27","author":"G Giardino","year":"2016","unstructured":"Giardino G, Somma D, Cirillo E, Ruggiero G, Terrazzano G, Rubino V, et al. Novel STAT1 gain-of-function mutation and suppurative infections. Pediatr Allergy Immunol. 2016;27(2):220\u20133.","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"847_CR125","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","volume":"135","author":"E Higgins","year":"2015","unstructured":"Higgins E, Al Shehri T, McAleer MA, Conlon N, Feighery C, Lilic D, et al. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. J Allergy Clin Immunol. 2015;135(2):551\u20133.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"847_CR126","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10875-018-0554-3","volume":"38","author":"SP Hartono","year":"2018","unstructured":"Hartono SP, Vargas-Hernandez A, Ponsford MJ, Chinn IK, Jolles S, Wilson K, et al. Novel STAT1 gain-of-function mutation presenting as combined immunodeficiency. J Clin Immunol. 2018;38(7):753\u20136.","journal-title":"J Clin Immunol"},{"issue":"8","key":"847_CR127","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10875-013-9947-5","volume":"33","author":"JC Aldave","year":"2013","unstructured":"Aldave JC, Cachay E, Nunez L, Chunga A, Murillo S, Cypowyj S, et al. A 1-year-old girl with a gain-of-function STAT1 mutation treated with hematopoietic stem cell transplantation. J Clin Immunol. 2013;33(8):1273\u20135.","journal-title":"J Clin Immunol"},{"issue":"1","key":"847_CR128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpeds.2013.02.040","volume":"163","author":"M Al Rushood","year":"2013","unstructured":"Al Rushood M, McCusker C, Mazer B, Alizadehfar R, Grimbacher B, Depner M, et al. Autosomal dominant cases of chronic mucocutaneous candidiasis segregates with mutations of signal transducer and activator of transcription 1, but not of Toll-like receptor 3. J Pediatr. 2013;163(1):277\u20139.","journal-title":"J Pediatr"},{"key":"847_CR129","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fped.2019.00160","volume":"7","author":"SE Henrickson","year":"2019","unstructured":"Henrickson SE, Dolan JG, Forbes LR, Vargas-Hernandez A, Nishimura S, Okada S, et al. Gain-of-function STAT1 mutation with familial lymphadenopathy and Hodgkin lymphoma. Front Pediatr. 2019;7:160.","journal-title":"Front Pediatr"},{"issue":"6","key":"847_CR130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/cge.13632","volume":"96","author":"E Stellacci","year":"2019","unstructured":"Stellacci E, Moneta GM, Bruselles A, Barresi S, Pizzi S, Torre G, et al. The activating p.Ser466Arg change in STAT1 causes a peculiar phenotype with features of interferonopathies. Clin Genet. 2019;96(6):585\u20139.","journal-title":"Clin Genet"},{"key":"847_CR131","doi-asserted-by":"crossref","unstructured":"Acker KP, Borlack R, Iuga A, Remotti HE, Soderquist C, Okada S, et al. Ruxolitinib response in an infant with very-early-onset inflammatory bowel disease and gain-of-function STAT1 mutation. J Pediatr Gastroenterol Nutr. 2020.","DOI":"10.1097\/MPG.0000000000002854"},{"issue":"5","key":"847_CR132","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","volume":"139","author":"KG Weinacht","year":"2017","unstructured":"Weinacht KG, Charbonnier LM, Alroqi F, Plant A, Qiao Q, Wu H, et al. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation. J Allergy Clin Immunol. 2017;139(5):1629\u201340 e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"847_CR133","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10875-018-0536-5","volume":"38","author":"H Al Dhanhani","year":"2018","unstructured":"Al Dhanhani H, Al Shehri T, Lilic D, Buddles M, Kisand K, Maccari ME, et al. Double trouble? CMC with a mutation in both AIRE and STAT1. J Clin Immunol. 2018;38(6):635\u20137.","journal-title":"J Clin Immunol"},{"issue":"1","key":"847_CR134","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2015.12.1320","volume":"138","author":"A Sobh","year":"2016","unstructured":"Sobh A, Chou J, Schneider L, Geha RS, Massaad MJ. Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation. J Allergy Clin Immunol. 2016;138(1):297\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"847_CR135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2017.00274","volume":"8","author":"K Meesilpavikkai","year":"2017","unstructured":"Meesilpavikkai K, Dik WA, Schrijver B, Nagtzaam NM, van Rijswijk A, Driessen GJ, et al. A novel heterozygous mutation in the STAT1 SH2 domain causes chronic mucocutaneous candidiasis, atypically diverse infections, autoimmunity, and impaired cytokine regulation. Front Immunol. 2017;8:274.","journal-title":"Front Immunol"},{"issue":"1","key":"847_CR136","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2018.02.045","volume":"142","author":"K Meesilpavikkai","year":"2018","unstructured":"Meesilpavikkai K, Dik WA, Schrijver B, Nagtzaam NMA, Posthumus-van Sluijs SJ, van Hagen PM, et al. Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1). J Allergy Clin Immunol. 2018;142(1):328\u201330 e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"847_CR137","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jaci.2017.07.027","volume":"141","author":"EP Sampaio","year":"2018","unstructured":"Sampaio EP, Ding L, Rose SR, Cruz P, Hsu AP, Kashyap A, et al. Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function. J Allergy Clin Immunol. 2018;141(5):1844\u201353 e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"15","key":"847_CR138","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1074\/jbc.M116.753848","volume":"292","author":"R Fujiki","year":"2017","unstructured":"Fujiki R, Hijikata A, Shirai T, Okada S, Kobayashi M, Ohara O. Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation. J Biol Chem. 2017;292(15):6240\u201354.","journal-title":"J Biol Chem"},{"key":"847_CR139","doi-asserted-by":"crossref","unstructured":"Sakata S, Tsumura M, Matsubayashi T, Karakawa S, Kimura S, Tamaura M, et al. Autosomal recessive complete STAT1 deficiency caused by compound heterozygous intronic mutations. Int Immunol. 2020.","DOI":"10.1093\/intimm\/dxaa043"},{"issue":"24","key":"847_CR140","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1093\/bioinformatics\/bty536","volume":"34","author":"P Zhang","year":"2018","unstructured":"Zhang P, Bigio B, Rapaport F, Zhang SY, Casanova JL, Abel L, et al. PopViz: a webserver for visualizing minor allele frequencies and damage prediction scores of human genetic variations. Bioinformatics. 2018;34(24):4307\u20139.","journal-title":"Bioinformatics"},{"issue":"10","key":"847_CR141","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.201445344","volume":"45","author":"J Zheng","year":"2015","unstructured":"Zheng J, van de Veerdonk FL, Crossland KL, Smeekens SP, Chan CM, Al Shehri T, et al. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC). Eur J Immunol. 2015;45(10):2834\u201346.","journal-title":"Eur J Immunol"},{"key":"847_CR142","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3389\/fimmu.2017.00820","volume":"8","author":"O Zimmerman","year":"2017","unstructured":"Zimmerman O, Rosen LB, Swamydas M, Ferre EMN, Natarajan M, van de Veerdonk F, et al. Autoimmune regulator deficiency results in a decrease in STAT1 levels in human monocytes. Front Immunol. 2017;8:820.","journal-title":"Front Immunol"},{"issue":"7","key":"847_CR143","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10875-018-0557-0","volume":"38","author":"AR Bernasconi","year":"2018","unstructured":"Bernasconi AR, Yancoski J, Villa M, Oleastro MM, Galicchio M, Rossi JG. Increased STAT1 amounts correlate with the Phospho-STAT1 level in STAT1 gain-of-function defects. J Clin Immunol. 2018;38(7):745\u20137.","journal-title":"J Clin Immunol"},{"issue":"6","key":"847_CR144","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molcel.2005.02.021","volume":"17","author":"X Mao","year":"2005","unstructured":"Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, et al. Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell. 2005;17(6):761\u201371.","journal-title":"Mol Cell"},{"issue":"11","key":"847_CR145","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1073\/pnas.0501063102","volume":"102","author":"M Zhong","year":"2005","unstructured":"Zhong M, Henriksen MA, Takeuchi K, Schaefer O, Liu B, ten Hoeve J, et al. Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc Natl Acad Sci U S A. 2005;102(11):3966\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"847_CR146","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1101\/gad.1485406","volume":"20","author":"C Mertens","year":"2006","unstructured":"Mertens C, Zhong M, Krishnaraj R, Zou W, Chen X, Darnell JE Jr. Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. Genes Dev. 2006;20(24):3372\u201381.","journal-title":"Genes Dev"},{"issue":"1","key":"847_CR147","first-page":"e28087","volume":"3","author":"FD Bohmer","year":"2014","unstructured":"Bohmer FD, Friedrich K. Protein tyrosine phosphatases as wardens of STAT signaling. JAKSTAT. 2014;3(1):e28087.","journal-title":"JAKSTAT."},{"issue":"4","key":"847_CR148","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/intimm\/dxz079","volume":"32","author":"M Tamaura","year":"2020","unstructured":"Tamaura M, Satoh-Takayama N, Tsumura M, Sasaki T, Goda S, Kageyama T, et al. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice. Int Immunol. 2020;32(4):259\u201372.","journal-title":"Int Immunol"},{"issue":"5","key":"847_CR149","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jir.2010.0115","volume":"31","author":"H Liu","year":"2011","unstructured":"Liu H, Rohowsky-Kochan C. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. J Interf Cytokine Res. 2011;31(5):459\u201369.","journal-title":"J Interf Cytokine Res"},{"issue":"7","key":"847_CR150","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","volume":"205","author":"CS Ma","year":"2008","unstructured":"Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205(7):1551\u20137.","journal-title":"J Exp Med"},{"issue":"4","key":"847_CR151","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaci.2015.05.036","volume":"136","author":"CS Ma","year":"2015","unstructured":"Ma CS, Wong N, Rao G, Avery DT, Torpy J, Hambridge T, et al. Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. J Allergy Clin Immunol. 2015;136(4):993\u20131006 e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"847_CR152","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20151467","volume":"213","author":"CS Ma","year":"2016","unstructured":"Ma CS, Wong N, Rao G, Nguyen A, Avery DT, Payne K, et al. Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets. J Exp Med. 2016;213(8):1589\u2013608.","journal-title":"J Exp Med"},{"issue":"3","key":"847_CR153","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jid.2017.09.035","volume":"138","author":"J Hiller","year":"2018","unstructured":"Hiller J, Hagl B, Effner R, Puel A, Schaller M, Mascher B, et al. STAT1 gain-of-function and dominant negative STAT3 mutations impair IL-17 and IL-22 immunity associated with CMC. J Invest Dermatol. 2018;138(3):711\u20134.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"847_CR154","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","volume":"179","author":"VL Bryant","year":"2007","unstructured":"Bryant VL, Ma CS, Avery DT, Li Y, Good KL, Corcoran LM, et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol. 2007;179(12):8180\u201390.","journal-title":"J Immunol"},{"issue":"1","key":"847_CR155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.20091706","volume":"207","author":"DT Avery","year":"2010","unstructured":"Avery DT, Deenick EK, Ma CS, Suryani S, Simpson N, Chew GY, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med. 2010;207(1):155\u201371.","journal-title":"J Exp Med"},{"key":"847_CR156","first-page":"319","volume":"7","author":"Y Wu","year":"2016","unstructured":"Wu Y, van Besouw NM, Shi Y, Hoogduijn MJ, Wang L, Baan CC. The biological effects of IL-21 signaling on B-cell-mediated responses in organ transplantation. Front Immunol. 2016;7:319.","journal-title":"Front Immunol"},{"issue":"12","key":"847_CR157","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","volume":"213","author":"MP Rodero","year":"2016","unstructured":"Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016;213(12):2527\u201338.","journal-title":"J Exp Med"},{"key":"847_CR158","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","volume":"1238","author":"YJ Crow","year":"2011","unstructured":"Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011;1238:91\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"847_CR159","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10875-018-0543-6","volume":"38","author":"YJ Crow","year":"2018","unstructured":"Crow YJ, Lebon P, Casanova JL, Gresser I. A brief historical perspective on the pathological consequences of excessive type I interferon exposure in vivo. J Clin Immunol. 2018;38(6):694\u20138.","journal-title":"J Clin Immunol"},{"key":"847_CR160","doi-asserted-by":"crossref","unstructured":"Mar\u00f3di L. Mucocutaneous candidiasis. Stiehm's Immune Deficiencies 2014. p. 775\u2013802.","DOI":"10.1016\/B978-0-12-405546-9.00040-6"},{"issue":"7","key":"847_CR161","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow YJ, Manel N. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15(7):429\u201340.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"847_CR162","first-page":"451","volume":"7","author":"C Selmi","year":"2006","unstructured":"Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME. Interferon alpha and its contribution to autoimmunity. Curr Opin Investig Drugs. 2006;7(5):451\u20136.","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"847_CR163","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng.748","volume":"43","author":"TA Briggs","year":"2011","unstructured":"Briggs TA, Rice GI, Daly S, Urquhart J, Gornall H, Bader-Meunier B, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet. 2011;43(2):127\u201331.","journal-title":"Nat Genet"},{"issue":"5","key":"847_CR164","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ni.3420","volume":"17","author":"I Meyts","year":"2016","unstructured":"Meyts I, Casanova JL. A human inborn error connects the alpha's. Nat Immunol. 2016;17(5):472\u20134.","journal-title":"Nat Immunol"},{"issue":"1","key":"847_CR165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20\u20131.","journal-title":"Nat Genet"},{"issue":"6","key":"847_CR166","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1086\/605532","volume":"49","author":"DC Vinh","year":"2009","unstructured":"Vinh DC, Masannat F, Dzioba RB, Galgiani JN, Holland SM. Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2009;49(6):e62\u20135.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"847_CR167","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/432120","volume":"41","author":"CS Zerbe","year":"2005","unstructured":"Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2005;41(4):e38\u201341.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"847_CR168","doi-asserted-by":"crossref","first-page":"ofw093","DOI":"10.1093\/ofid\/ofw093","volume":"3","author":"N Pruetpongpun","year":"2016","unstructured":"Pruetpongpun N, Khawcharoenporn T, Damronglerd P, Suthiwartnarueput W, Apisarnthanarak A, Rujanavej S, et al. Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies. Open Forum Infect Dis. 2016;3(2):ofw093.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"847_CR169","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725\u201334.","journal-title":"N Engl J Med"},{"issue":"1","key":"847_CR170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000248386","volume":"178","author":"D Leroy","year":"1989","unstructured":"Leroy D, Dompmartin A, Houtteville JP, Theron J. Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. Dermatologica. 1989;178(1):43\u20136.","journal-title":"Dermatologica"},{"issue":"4","key":"847_CR171","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00431-007-0490-3","volume":"167","author":"MG Marazzi","year":"2008","unstructured":"Marazzi MG, Bondi E, Giannattasio A, Strozzi M, Savioli C. Intracranial aneurysm associated with chronic mucocutaneous candidiasis. Eur J Pediatr. 2008;167(4):461\u20133.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"847_CR172","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006454-200102000-00017","volume":"20","author":"CH Kirkpatrick","year":"2001","unstructured":"Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 2001;20(2):197\u2013206.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"847_CR173","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCGENETICS.111.961235","volume":"5","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Azarine A, Ong KT, Taleb S, Boutouyrie P, Mousseaux E, et al. Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ Cardiovasc Genet. 2012;5(1):25\u201334.","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"847_CR174","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","volume":"142","author":"LR Forbes","year":"2018","unstructured":"Forbes LR, Vogel TP, Cooper MA, Castro-Wagner J, Schussler E, Weinacht KG, et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J Allergy Clin Immunol. 2018;142(5):1665\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"847_CR175","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/ciw020","volume":"62","author":"R Mossner","year":"2016","unstructured":"Mossner R, Diering N, Bader O, Forkel S, Overbeck T, Gross U, et al. Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation. Clin Infect Dis. 2016;62(7):951\u20133.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"847_CR176","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.imlet.2015.05.008","volume":"167","author":"FL van de Veerdonk","year":"2015","unstructured":"van de Veerdonk FL, Koenen HJ, van der Velden WJ, van der Meer JW, Netea MG. Immunotherapy with G-CSF in patients with chronic mucocutaneous candidiasis. Immunol Lett. 2015;167(1):54\u20136.","journal-title":"Immunol Lett"},{"issue":"Suppl","key":"847_CR177","first-page":"S56","volume":"72","author":"FL van de Veerdonk","year":"2016","unstructured":"van de Veerdonk FL, Netea MG. Treatment options for chronic mucocutaneous candidiasis. J Inf Secur. 2016;72(Suppl):S56\u201360.","journal-title":"J Inf Secur"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00847-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00847-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T07:05:30Z","timestamp":1696575930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00847-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":177,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00847-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}